コンテンツへスキップ
Merck

Illustrative cases of unorthodox tinnitus management.

Noise & health (2013-04-11)
Kenneth H Brookler
要旨

Bone remodeling disorders have been identified as potential candidates for the etiology underlying some forms of otologic disease. Here, four clinical cases are presented to demonstrate a novel approach to tinnitus management that focuses on two fundamental etiologic bases. First, is the effect of bone remodeling abnormalities of the otic capsule and second, the effect of blood sugar and insulin abnormalities upon the function of the inner ear and self-reports of tinnitus. This report presents the effect of treatment directed at bone remodeling abnormalities of the otic capsule and abnormalities of blood sugar and insulin. The treatment effects led to a substantial reduction in subjective tinnitus. These findings suggest a potential convergence between bone pathophysiology and some forms of tinnitus.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
フッ化ナトリウム, ACS reagent, ≥99%
Sigma-Aldrich
フッ化ナトリウム, ReagentPlus®, ≥99%
Sigma-Aldrich
フッ化ナトリウム, 99.99% trace metals basis
Sigma-Aldrich
フッ化ナトリウム, anhydrous, powder, 99.99% trace metals basis
Sigma-Aldrich
フッ化ナトリウム, puriss., meets analytical specification of Ph. Eur., BP, USP, 98.5-100.5% (calc. to the dried substance)
Sigma-Aldrich
フッ化ナトリウム, BioXtra, ≥99%
Sigma-Aldrich
フッ化ナトリウム溶液
Sigma-Aldrich
フッ化ナトリウム, BioReagent, suitable for insect cell culture, ≥99%
Sigma-Aldrich
フッ化ナトリウム0.5 M 溶液
Supelco
Fluoride ion solution for ISE, 0.1 M F-, analytical standard (for ion-selective electrodes)
Sigma-Aldrich
Fluoride standard solution, 1 mg/mL F-
Sigma-Aldrich
フッ化ナトリウム, SAJ first grade, ≥97.0%
Sigma-Aldrich
フッ化ナトリウム, JIS special grade, ≥99.0%